WRAPHIGH SIGNALFINANCIAL10-K

WRAP's financial condition deteriorated significantly with substantially higher net losses despite meaningful reductions in R&D spending and total liabilities.

The company's net losses expanded substantially while R&D expenses were cut to minimal levels, suggesting potential constraints on innovation investment. The significant reduction in liabilities may indicate debt restructuring or settlement, but the worsening cash burn and operating performance raise concerns about the company's ability to sustain operations without additional capital.

Comparing 2026-03-26 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

WRAP's financial picture presents mixed signals with concerning operational trends. While the company meaningfully reduced its liability burden and cut R&D expenses to minimal levels, net losses expanded substantially and operating cash flow deteriorated further. The reduction in current liabilities by 86% suggests possible debt restructuring, but the underlying business performance shows continued stress with worsening cash burn despite cost-cutting measures.

FINANCIAL STATEMENT CHANGES
R&D Expense
P&L
-97.6%
$2.3M$56K

R&D spending cut 97.6% — could signal cost discipline or concerning reduction in innovation investment.

Current Liabilities
Balance Sheet
-86.2%
$13.2M$1.8M

Current liabilities reduced — improved short-term financial position and working capital health.

Net Income
P&L
-75.9%
-$5.9M-$10.3M

Net income declined 75.9% — review whether driven by operations, interest costs, or non-recurring items.

Total Liabilities
Balance Sheet
-73.6%
$14.9M$3.9M

Liabilities reduced 73.6% — deleveraging improves balance sheet strength and financial flexibility.

Operating Cash Flow
Cash Flow
-26.6%
-$8.1M-$10.3M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Inventory
Balance Sheet
-19.4%
$6.2M$5.0M

Inventory reduced 19.4% — lean inventory management or demand outpacing supply.

Operating Income
P&L
+13.4%
-$15.6M-$13.5M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

LANGUAGE CHANGES
NEW — 2026-03-26
PRIOR — 2025-03-31
ADDED
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
A s of March 23 , 2026 a total of 55,500,054 shares of common stock, par value $0.0001 per share, were outstanding.
Additional discussion of the risks summarized in this risk factor summary, and other risks that we face, can be found under the heading Risk Factors in Part I, Item 1A of this Annual Report on Form 10-K and should be carefully considered, together with other information in this Form 10-K and our other filings with the SEC, before making an investment decision regarding our Common Stock.
Risks Relating to Business and Industry We have a history of operating losses and may never achieve or sustain profitability.
We may need to raise additional capital, which may not be available on favorable terms or at all, and which may cause dilution to our stockholders.
+7 more — sign up free →
REMOVED
As of March 25, 2025, 50,494,701 shares of common stock, par value $ 0.0001 per share, were outstanding.
TRADEMARKS, TRADE NAMES AND SERVICE MARKS Our trademarks include Wrap, the Wrap logo, BolaWrap , and Wrap Reality , Intrensic, and Evidence on A Cloud, some of which are registered trademarks in the US and certain other jurisdictions.
BUSINESS Overview We are a global public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide.
We are leading the movement for safer outcomes by equipping law enforcement with safer, non-painful compliance tools, and immersive training fit for modern society.
The BolaWrap 150 is electronically deployed and is more robust, smaller, lighter and simpler to deploy than the BolaWrap 100 that has since been phased out.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →